Lab
Palo Alto Pathology, INC
Palo Alto Pathology, INC was paid $1.57M by Medicaid between Jan 2018 and Nov 2024, across 13 billing codes. Its largest line is 88175, Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer — 18% of everything it billed.
33Billing provider infoPALO ALTO PATHOLOGY, INC
PALO ALTO, CA 94306
PALO ALTO, CA 94306
33aNPI1568509727assigned 01/30/2007
33bProvider typeClinical Medical Laboratory
28Total paid$1.57M
24GClaims66,432
24DCodes billed13
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#164 of 561
Median peer was paid$222K
This provider vs. median7.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,079 | $269K | |
| 2019 | 9,749 | $242K | |
| 2020 | 7,491 | $173K | |
| 2021 | 9,238 | $213K | |
| 2022 | 9,701 | $216K | |
| 2023 | 10,257 | $231K | |
| 2024incomplete | 9,917 | $230K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 18% | 13,598 | 13,537 | $284K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 15% | 8,381 | 8,263 | $236K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15% | 8,006 | 7,958 | $232K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14% | 7,911 | 7,864 | $228K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 8.6% | 3,602 | 1,590 | $136K |
| 87653 | 5.8% | 3,212 | 3,109 | $91K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.8% | 1,906 | 1,852 | $91K |
| 87660 | 5.4% | 4,743 | 4,700 | $85K | |
| 88141 | 5.3% | 9,386 | 9,372 | $83K | |
| 87510 | 3.4% | 2,846 | 2,783 | $54K | |
| 87480 | 3.4% | 2,789 | 2,736 | $53K | |
| 87625 | <1% | 39 | 39 | $801.75 |
1 more codes
| 87529 | <1% | 13 | $325.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHADLER, KENNETH (PRESIDENT, CEO)